Misoprostol versus expectant management in premature rupture of membranes at term
- PMID: 16101609
- DOI: 10.1111/j.1471-0528.2005.00700.x
Misoprostol versus expectant management in premature rupture of membranes at term
Abstract
Objective: To compare the effectiveness of immediate induction of labour with vaginal misoprostol versus expectant management for 24 hours followed by oxytocin induction in women with premature rupture of membranes at term (term PROM).
Design: An open, randomised, controlled trial.
Setting: Public university hospital in Campinas City, Brazil.
Population: One hundred and fifty pregnancies, half of them allocated to each group.
Methods: Statistical analysis used Student's t test, the chi2 test, Fisher's exact test, survival analysis and risk ratio estimates with 95% CI.
Main outcome measures: Latency period, recruitment to delivery period, period of hospitalisation, mode of delivery, contractility pattern, fetal wellbeing, labour and delivery complications, neonatal and maternal morbidity.
Results: Both groups had similar general characteristics, but the misoprostol group had a significantly shorter latency period (9.4 vs 15.8 hours), a shorter time interval from recruitment to delivery (18.9 vs 27.5 hours), a shorter period of maternal hospitalisation and a slightly higher proportion of alterations of contractility when compared with the expectant group. Caesarean section rates were 20% in the misoprostol group and 30.7% in the other. There were no differences between them regarding fetal wellbeing, complications during labour and delivery and neonatal or postpartum maternal morbidity. Within 24 hours, 44% of women had delivered in the expectant group against 73.3% in the misoprostol group.
Conclusions: Immediate labour induction with misoprostol in cases of term PROM shortens the latency period, the total time between recruitment to delivery and the time of maternal hospitalisation, increasing the occurrence of alterations of contractility without any maternal and perinatal outcomes disadvantages.
Similar articles
-
Titrated low-dose vaginal and/or oral misoprostol to induce labour for prelabour membrane rupture: a randomised trial.BJOG. 2008 Nov;115(12):1503-11. doi: 10.1111/j.1471-0528.2008.01890.x. Epub 2008 Aug 25. BJOG. 2008. PMID: 18752586 Clinical Trial.
-
Comparison of vaginal misoprostol tablets and prostaglandin E2 gel for the induction of labor in premature rupture of membranes at term: a randomized comparative trial.J Obstet Gynaecol Res. 2011 Nov;37(11):1564-71. doi: 10.1111/j.1447-0756.2011.01575.x. Epub 2011 Jun 16. J Obstet Gynaecol Res. 2011. PMID: 21676083 Clinical Trial.
-
Comparative efficacy and safety of vaginal misoprostol versus dinoprostone vaginal insert in labor induction at term: a randomized trial.Arch Gynecol Obstet. 2009 Jul;280(1):19-24. doi: 10.1007/s00404-008-0843-9. Epub 2008 Nov 26. Arch Gynecol Obstet. 2009. PMID: 19034471 Clinical Trial.
-
A retrospective review of pregnancy outcome after misoprostol (prostaglandin E1) induction of labour.West Indian Med J. 2001 Mar;50(1):47-9. West Indian Med J. 2001. PMID: 11398287 Review.
-
[Term Prelabor Rupture of Membranes: CNGOF Guidelines for Clinical Practice - Timing of Labor Induction].Gynecol Obstet Fertil Senol. 2020 Jan;48(1):35-47. doi: 10.1016/j.gofs.2019.10.015. Epub 2019 Oct 25. Gynecol Obstet Fertil Senol. 2020. PMID: 31669525 Review. French.
Cited by
-
Premature rupture of membrane at term: early induction versus expectant management.J Obstet Gynaecol India. 2012 Apr;62(2):172-5. doi: 10.1007/s13224-012-0172-6. Epub 2012 Jun 1. J Obstet Gynaecol India. 2012. PMID: 23543046 Free PMC article.
-
Use of labour induction and risk of cesarean delivery: a systematic review and meta-analysis.CMAJ. 2014 Jun 10;186(9):665-73. doi: 10.1503/cmaj.130925. Epub 2014 Apr 28. CMAJ. 2014. PMID: 24778358 Free PMC article.
-
Misoprostol use in obstetrics.Rev Bras Ginecol Obstet. 2023 Jun;45(6):356-368. doi: 10.1055/s-0043-1770931. Epub 2023 Jul 21. Rev Bras Ginecol Obstet. 2023. PMID: 37494579 Free PMC article. No abstract available.
-
Intravaginal Misoprostol for Cervical Ripening and Labor Induction in Nulliparous Women: A Double-blinded, Prospective Randomized Controlled Study.Chin Med J (Engl). 2015 Oct 20;128(20):2736-42. doi: 10.4103/0366-6999.167299. Chin Med J (Engl). 2015. PMID: 26481739 Free PMC article. Clinical Trial.
-
Vaginal misoprostol for cervical ripening and induction of labour.Cochrane Database Syst Rev. 2010 Oct 6;2010(10):CD000941. doi: 10.1002/14651858.CD000941.pub2. Cochrane Database Syst Rev. 2010. PMID: 20927722 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources